bioRxivMolecular BiologyPreprint
Merkel cell polyomavirus infection and persistence modelled in skin organoids
Silvia AlbertiniiD, Manja Czech‐SioliiD, Thomas GüntheriD, Sanamjeet VirdiiD, Patrick BlümkeiD, Lisann Röpke, Veronika Brinschwitz, Maura DandriiD, Lena AllweissiD, Rudolf Reimer, Carola Schneider, Arne HanseniD, Susanne KrasemanniD, Emanuel WyleriD, Markus LandthaleriD, Adam T. GrundhoffiD, Nicole FischeriD
Abstract
Merkel cell polyomavirus (MCPyV) causes most Merkel cell carcinomas (MCC). The virus is one of the few known human tumor viruses, and due to its direct role in this skin cancer development, it is a bona fide model for viral tumorigenesis and tumorigenesis in general. Chronic viruses in humans such as MCPyV are highly adapted to their host and current models to study infection, persistence and pathogenesis are highly limited. We here use an induced pluripotent stem cell (iPSC)-derived hair-bearing skin organoid (SkO) system to demonstrate efficient viral infection, progression and spread of MCPyV. Using bulk-, single cell - and spatial-transcriptomics, combined with immunostaining and nucleic acid hybridization technologies, we show that MCPyV ensures persistence due to a quasi-latency state within the majority of dermal fibroblasts carry the viral genome. Further, we identify the cell type of productive infection with papillary fibroblasts and dermal sheath fibroblasts supporting viral replication and progeny production. Our high-resolution methods demonstrate that the virus in these cells evades the innate immune response, as evidenced by the efficacy of interferon-beta treatment or ruxolitinib, a JAK/STAT inhibitor, in suppressing or stimulating viral replication. We show that iPSC-derived SkOs are able to support infection and long-term persistence of the virus under conditions very similar to those found in humans. Thus, this infection model provides a robust platform for understanding and characterizing the interaction of this virus with the immune system in infection, testing treatment strategies to control reactivation and map processes involved in tumor development.
- organism: human
- assay: bulk RNA-seq
- assay: spatial transcriptomics
- research focus: cell type annotation
- research focus: differential expression
- approach: experimental assay
- Citations
- 4
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Infectious Entry of Merkel Cell Polyomavirus
M. Becker, M. Dominguez, … M. Schelhaas·bioRxiv·Oct 30, 2018
- Cell Cycle Regulation of Merkel Cell Polyomavirus Replication and Genome Inheritance in Single Cells
Steven W. Smeal, Hongzhao Zhou, … Robin Lee·bioRxiv·Aug 3, 2026
- Delta-catenin is required for cell proliferation in virus positive Merkel cell carcinoma cell lines but not in human fibroblasts
Joselyn Landazuri Vinueza, Nicholas J. H. Salisbury, … Denise A. Galloway·mBioPeer-reviewed·May 23, 2025
- Merkel cell polyomavirus small tumor antigen contributes to immune evasion by interfering with type I interferon signaling
Denise Ohnezeit, Jiabin Huang, … Nicole Fischer·PLoS PathogensPeer-reviewed·Aug 7, 2024
- Merkel cell polyomavirus protein ALTO modulates TBK1 activity to support persistent infection
R. Wang, T. E. Senay, … J. You·PLOS PathogensPeer-reviewed·Jul 29, 2024
- An immunocompetent model of MCPyV-driven Merkel cell carcinoma reveals tumor evolution under immune selection
James M. Regan, Xiaomei Li, … Jianxin You·bioRxiv·Jul 13, 2026